Dual [ 68 Ga]DOTATATE and [ 18 F]FDG PET/CT in patients with metastatic gastroenteropancreatic neuroendocrine neoplasms: a multicentre validation of the NETPET score.
David L ChanAimee R HayesIoannis KarfisAlice ConnerLuke Furtado O'MahonyMagdalena MilevaElizabeth BernardPaul RoachGwennaëlle MarinNick PavlakisGeoffrey SchembriGopinath GnanasegaranClementine MarinBruno VanderlindenShaunak NavalkissoorMartyn E CaplinPatrick FlamenChristos ToumpanakisDale L BaileyPublished in: British journal of cancer (2022)
This study validates the NETPET score as a prognostic biomarker in metastatic GEPNENs, capturing the complexity of dual PET imaging.